Ligand id: 9039

Name: erdafitinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 77.33
Molecular weight 446.24
XLogP 3.1
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Erdafitinib is being evaluated as a monotherapy in Phase II clinical trial for its antineoplastic activity in patients with urothelial cancer (see NCT02365597).